Financial Results
First Quarter 2024 Financial Results
Genmab will present its financial results for the first quarter of 2024 on May 2, 2024.
We are focused on our vision of transforming the future of cancer treatment.
We aim to share relevant, accurate and timely information with our investors.
With innovations, partnerships and presentations, we are making headlines.
Our passion for innovation is driven by data and rooted in science.
We know the value of finding and being good partners.
We are committed to make an impact on the lives of people with cancer.
Join our team of extra[not]ordinary™ people and become part of a company working to pioneer antibody medicines for cancer and other serious diseases.